Antibodies and Antimatter: The Resurgence of Immuno-PET
Open accessThe DOI matches its Crossref record.
Abstract
The completion of the human genome, coupled with parallel major research efforts in proteomics and systems biology, has led to a flood of information on the roles of individual genes and proteins in normal physiologic processes and their disruptions in disease. In practical terms, this information has opened the door to increasingly targeted therapies as specific molecular markers are identified and validated. The ongoing transition from empiric to molecular medicine has engendered a need for corresponding molecular diagnostics, including noninvasive molecular imaging. Convergence of knowledge regarding key biomarkers that define normal biologic processes and disease with protein and imaging technology makes this an opportune time to revisit the combination of antibodies and PET, or immuno-PET.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
Trebeschi, S., Drago, S. G., Birkbak, N. J., Kurilova, I., Cǎlin, A. M., Delli Pizzi, A., Lalezari, F., Lambregts, D. M. J., Rohaan, M. W., Parmar, C., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz108 · Cited by 566
Standardized methods for the production of high specific-activity zirconium-89
Holland, J. P., Sheh, Y., & Lewis, J. S. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.05.007 · Cited by 408
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
Tavaré, R., Escuin-Ordinas, H., Mok, S., McCracken, M. N., Zettlitz, K. A., Salazar, F. B., Witte, O. N., Ribas, A., & Wu, A. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1707 · Cited by 320
Self-citationRadiochemistry for positron emission tomography
Rong, J., Haider, A., Jeppesen, T. E., Josephson, L., & Liang, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-36377-4 · Cited by 294
Click Chemistry and Radiochemistry: The First 10 Years
Meyer, J.-P., Adumeau, P., Lewis, J. S., & Zeglis, B. M. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00561 · Cited by 248
Zeglis, B. M., Davis, C. B., Aggeler, R., Kang, H. C., Chen, A., Agnew, B. J., & Lewis, J. S. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400122c · Cited by 160
“consists of four simple steps: (1) the enzymatic removal of terminal galactose residues on the Fc domain to expose terminal GlcNAc residues; (2) the enzymatic incorporation of GalNAz monosaccharides onto the terminal GlcNAc residues; (3) the catalyst-free, strainpromoted click conjugation of novel chelator-modified di…”
BackgroundMethodAssessments of antibody biodistribution
Glassman, P. M., Abuqayyas, L., & Balthasar, J. P. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.365 · Cited by 42
Metadata
- Authors
- Wu, A. M.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2008-12-17
- Volume
- 50
- Issue
- 1
- Pages
- 2-5
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2153750906
- Cited by
- 184
- References
- 0
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.